GLPwatch

CCK Response Deficiency in Synphilin-1 Transgenic Mice.

PLoS One · 2015

Last updated 2026-05-28

In a study of mice, those genetically modified to produce more of a protein called synphilin-1 (SP1) did not reduce their food intake after receiving cholecystokinin (CCK), a hormone that normally signals fullness. This effect was specific to CCK, as other hormones like amylin and GLP-1 (via exendin-4) still reduced food intake in these mice. The researchers also found that brain activity linked to CCK signaling was lower in the modified mice.

AI summary of the abstract below.

JournalPLoS One, 2015
Citations1
Relative citation ratio0.03
NIH percentile4
Molecules

Abstract

Previously, we have identified a novel role for the cytoplasmic protein, synphilin-1(SP1), in the controls of food intake and body weight in both mice and Drosophila. Ubiquitous overexpression of human SP1 in brain neurons in transgenic mice results in hyperphagia expressed as an increase in meal size. However, the mechanisms underlying this action of SP1 remain to be determined. Here we investigate a potential role for altered gut feedback signaling in the effects of SP1 on food intake. We examined responses to peripheral administration of cholecytokinin (CCK), amylin, and the glucagon like peptide-1 (GLP-1) receptor agonist, exendin-4. Intraperitoneal administration of CCK at doses ranging from 1-10 nmol/kg significantly reduced glucose intake in wild type (WT) mice, but failed to affect intake in SP1 transgenic mice. Moreover, there was a significant attenuation of CCK-induced c-Fos expression in the dorsal vagal complex in SP1 transgenic mice. In contrast, WT and SP1 transgenic mice were similarly responsive to both amylin and exendin-4 treatment. These studies demonstrate that SP1 results in a CCK response deficiency that may contribute to the increased meal size and overall hyperphagia in synphillin-1 transgenic mice.

Verbatim abstract via PubMed 26569394 ↗